A M Thompson|G C Thompson - JoVE Visualize

Showing results (201-210 of 211) with videos related to

Pageof 22

Sort By:

Journal of Medicinal Chemistry|November 7, 2000

3-(3,5-Dimethoxyphenyl)-1,6-naphthyridine-2,7-diamines and related 2-urea derivatives are potent and selective inhibitors of the FGF receptor-1 tyrosine kinaseA M Thompson, C J Connolly, J M Hamby, et al.

Oncogene|May 24, 2011

Integrative mRNA profiling comparing cultured primary cells with clinical samples reveals PLK1 and C20orf20 as therapeutic targets in cutaneous squamous cell carcinomaS A Watt, C Pourreyron, K Purdie, et al.

Journal of Medicinal Chemistry|February 14, 1997

Tyrosine kinase inhibitors. 6. Structure-activity relationships among N- and 3-substituted 2,2'-diselenobis(1H-indoles) for inhibition of protein tyrosine kinases and comparative in vitro and in vivo studies against selected sulfur congenersH D Showalter, A D Sercel, B M Leja, et al.

Vaccine|March 8, 2023

Willingness to vaccinate children against COVID-19 declined during the pandemicR D Goldman, R J Hart, J N Bone, et al.

Breast Cancer Research and Treatment|November 15, 2014

NEOCENT: a randomised feasibility and translational study comparing neoadjuvant endocrine therapy with chemotherapy in ER-rich postmenopausal primary breast cancerC Palmieri, S Cleator, L S Kilburn, et al.

Cancer Research|March 21, 1998

Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parametersC M Phelan, A Borg, M Cuny, et al.

Seminars in Cancer Biology|July 11, 2018

Scoring of tumor-infiltrating lymphocytes: From visual estimation to machine learningF Klauschen, K-R Müller, A Binder, et al.

NPJ Breast Cancer|May 6, 2026

Enabling DCIS subtyping: leveraging foundation models for robust grading and molecular biomarker scoringS Doyle, M A Oerlemans, J Brunekreef, et al.

The British Journal of Surgery|March 24, 2021

Bridging the age gap in breast cancer: cluster randomized trial of two decision support interventions for older women with operable breast cancer on quality of life, survival, decision quality, and treatment choicesL Wyld, M W R Reed, K Collins, et al.

Atmospheric Measurement Techniques|May 11, 2018

Ground-based assessment of the bias and long-term stability of fourteen limb and occultation ozone profile data recordsD Hubert, J-C Lambert, T Verhoelst, et al.

Pageof 22

Showing results (201-210 of 211) with videos related to

Sort By:

Pageof 22

Journal of Medicinal Chemistry|November 7, 2000

3-(3,5-Dimethoxyphenyl)-1,6-naphthyridine-2,7-diamines and related 2-urea derivatives are potent and selective inhibitors of the FGF receptor-1 tyrosine kinaseA M Thompson, C J Connolly, J M Hamby, et al.

Oncogene|May 24, 2011

Integrative mRNA profiling comparing cultured primary cells with clinical samples reveals PLK1 and C20orf20 as therapeutic targets in cutaneous squamous cell carcinomaS A Watt, C Pourreyron, K Purdie, et al.

Journal of Medicinal Chemistry|February 14, 1997

Tyrosine kinase inhibitors. 6. Structure-activity relationships among N- and 3-substituted 2,2'-diselenobis(1H-indoles) for inhibition of protein tyrosine kinases and comparative in vitro and in vivo studies against selected sulfur congenersH D Showalter, A D Sercel, B M Leja, et al.

Vaccine|March 8, 2023

Willingness to vaccinate children against COVID-19 declined during the pandemicR D Goldman, R J Hart, J N Bone, et al.

Breast Cancer Research and Treatment|November 15, 2014

NEOCENT: a randomised feasibility and translational study comparing neoadjuvant endocrine therapy with chemotherapy in ER-rich postmenopausal primary breast cancerC Palmieri, S Cleator, L S Kilburn, et al.

Cancer Research|March 21, 1998

Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parametersC M Phelan, A Borg, M Cuny, et al.

Seminars in Cancer Biology|July 11, 2018

Scoring of tumor-infiltrating lymphocytes: From visual estimation to machine learningF Klauschen, K-R Müller, A Binder, et al.

NPJ Breast Cancer|May 6, 2026

Enabling DCIS subtyping: leveraging foundation models for robust grading and molecular biomarker scoringS Doyle, M A Oerlemans, J Brunekreef, et al.

The British Journal of Surgery|March 24, 2021

Bridging the age gap in breast cancer: cluster randomized trial of two decision support interventions for older women with operable breast cancer on quality of life, survival, decision quality, and treatment choicesL Wyld, M W R Reed, K Collins, et al.

Atmospheric Measurement Techniques|May 11, 2018

Ground-based assessment of the bias and long-term stability of fourteen limb and occultation ozone profile data recordsD Hubert, J-C Lambert, T Verhoelst, et al.

Pageof 22